Puma Biotechnology (PBYI) News Today → [PDF Inside] Crypto's $1 Trillion 60-Day Boom + New 2024 Profit Strategy (From DeFi Distribution) (Ad) Free PBYI Stock Alerts $3.48 -0.05 (-1.42%) (As of 01:12 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 7 at 5:37 PM | businesswire.comPuma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)June 3, 2024 | businesswire.comPuma Biotechnology Announces Presentation of Findings from a Phase I/Ib Study of Alisertib in Advanced EGFR-Mutated Lung CancerJune 3, 2024 | americanbankingnews.comPuma Biotechnology (NASDAQ:PBYI) Earns "Buy" Rating from HC WainwrightJune 2, 2024 | businesswire.comPuma Biotechnology Announces Presentation of Findings from a Phase II Study of Alisertib in Endocrine-Resistant Metastatic Breast Cancer (TBCRC 041)May 28, 2024 | businesswire.comPuma Biotechnology to Join Russell 3000 IndexMay 26, 2024 | finance.yahoo.comWith 49% ownership, Puma Biotechnology, Inc. (NASDAQ:PBYI) has piqued the interest of institutional investorsMay 23, 2024 | businesswire.comPuma Biotechnology Announces Publication of Alisertib Abstract Titles for the 2024 ASCO Annual MeetingMay 20, 2024 | marketbeat.comPuma Biotechnology (NASDAQ:PBYI) Given "Buy" Rating at HC WainwrightHC Wainwright restated a "buy" rating and set a $7.00 price objective on shares of Puma Biotechnology in a research report on Monday.May 5, 2024 | finance.yahoo.comAnalysts Have Lowered Expectations For Puma Biotechnology, Inc. (NASDAQ:PBYI) After Its Latest ResultsMay 4, 2024 | finance.yahoo.comPuma Biotechnology First Quarter 2024 Earnings: EPS Beats Expectations, Revenues LagMay 3, 2024 | marketbeat.comPuma Biotechnology (NASDAQ:PBYI) Rating Increased to Buy at StockNews.comStockNews.com upgraded shares of Puma Biotechnology from a "hold" rating to a "buy" rating in a report on Friday.May 3, 2024 | marketbeat.comPuma Biotechnology (NASDAQ:PBYI) Stock Rating Reaffirmed by HC WainwrightHC Wainwright reissued a "buy" rating and issued a $7.00 target price on shares of Puma Biotechnology in a report on Friday.May 3, 2024 | markets.businessinsider.comBuy Rating Affirmed for Puma Biotechnology Amid Strong Q1 Performance and Promising OutlookMay 3, 2024 | finance.yahoo.comPuma Biotechnology, Inc. (NASDAQ:PBYI) Q1 2024 Earnings Call TranscriptMay 3, 2024 | finance.yahoo.comPuma Biotechnology Inc (PBYI) Q1 2024 Earnings Call Transcript Highlights: A Detailed Review of ...May 2, 2024 | investorplace.comPBYI Stock Earnings: Puma Biotechnology Beats EPS, Beats Revenue for Q1 2024May 2, 2024 | msn.comPuma Biotechnology Non-GAAP EPS of -$0.05 beats by $0.10, revenue of $43.8M misses by $5.25MMay 2, 2024 | businesswire.comPuma Biotechnology Reports First Quarter Financial ResultsMay 1, 2024 | msn.comPuma Biotechnology Q1 2024 Earnings PreviewMay 1, 2024 | markets.businessinsider.comPuma Biotechnology is about to announce its earnings — here's what Wall Street expectsApril 29, 2024 | finance.yahoo.comIs Puma Biotechnology, Inc. (NASDAQ:PBYI) A High Quality Stock To Own?April 24, 2024 | nasdaq.comPBYI Crosses Above Average Analyst TargetApril 19, 2024 | investorplace.com7 Stocks Under $15 Predicted to Boom in the Next 2 YearsApril 18, 2024 | businesswire.comPuma Biotechnology to Host Conference Call to Discuss First Quarter 2024 Financial ResultsApril 10, 2024 | marketbeat.comPuma Biotechnology (NASDAQ:PBYI) Downgraded by StockNews.comStockNews.com lowered Puma Biotechnology from a "buy" rating to a "hold" rating in a report on Wednesday.April 8, 2024 | finance.yahoo.comPuma Biotechnology (NASDAQ:PBYI) shareholders have earned a 93% return over the last yearApril 5, 2024 | marketbeat.comEquities Analysts Issue Forecasts for Puma Biotechnology, Inc.'s FY2025 Earnings (NASDAQ:PBYI)Puma Biotechnology, Inc. (NASDAQ:PBYI - Free Report) - Equities researchers at Zacks Research cut their FY2025 earnings estimates for Puma Biotechnology in a research note issued to investors on Wednesday, April 3rd. Zacks Research analyst K. Shah now expects that the biopharmaceutical company wiApril 3, 2024 | businesswire.comPuma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)March 22, 2024 | finance.yahoo.comDo Puma Biotechnology's (NASDAQ:PBYI) Earnings Warrant Your Attention?March 22, 2024 | marketbeat.comQ1 2024 EPS Estimates for Puma Biotechnology, Inc. Decreased by Zacks Research (NASDAQ:PBYI)Puma Biotechnology, Inc. (NASDAQ:PBYI - Free Report) - Analysts at Zacks Research decreased their Q1 2024 EPS estimates for shares of Puma Biotechnology in a research note issued to investors on Tuesday, March 19th. Zacks Research analyst K. Shah now anticipates that the biopharmaceutical companyMarch 21, 2024 | marketbeat.comPuma Biotechnology, Inc. to Post FY2026 Earnings of $0.56 Per Share, Zacks Research Forecasts (NASDAQ:PBYI)Puma Biotechnology, Inc. (NASDAQ:PBYI - Free Report) - Analysts at Zacks Research issued their FY2026 earnings estimates for shares of Puma Biotechnology in a note issued to investors on Tuesday, March 19th. Zacks Research analyst K. Shah forecasts that the biopharmaceutical company will post earMarch 21, 2024 | marketbeat.comPuma Biotechnology (NASDAQ:PBYI) Share Price Crosses Above Two Hundred Day Moving Average of $4.13Puma Biotechnology (NASDAQ:PBYI) Stock Price Crosses Above Two Hundred Day Moving Average of $4.13March 20, 2024 | markets.businessinsider.comPuma Biotechnology: FDA Allows To Proceed With Clinical Development Of AlisertibMarch 20, 2024 | finance.yahoo.comPuma Biotechnology Announces FDA Allowance to Proceed Under IND for Alisertib in HER2-Negative, Hormone Receptor-Positive Metastatic Breast CancerMarch 2, 2024 | markets.businessinsider.comBuy Rating on Puma Biotechnology Amid Financial Challenges and Drug Advancement ProspectsMarch 2, 2024 | finance.yahoo.comPuma Biotechnology, Inc. (NASDAQ:PBYI) Shares Could Be 47% Below Their Intrinsic Value EstimateMarch 2, 2024 | seekingalpha.comPuma Biotechnology, Inc. (PBYI) Q4 2023 Earnings Call TranscriptMarch 1, 2024 | marketbeat.comPuma Biotechnology (NASDAQ:PBYI) PT Lowered to $7.00 at HC WainwrightHC Wainwright dropped their price objective on Puma Biotechnology from $8.00 to $7.00 and set a "buy" rating on the stock in a research report on Friday.February 29, 2024 | businesswire.comPuma Biotechnology Reports Fourth Quarter and Full Year 2023 Financial ResultsFebruary 27, 2024 | finance.yahoo.comPuma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)February 27, 2024 | businesswire.comPuma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)February 22, 2024 | finance.yahoo.comPuma Biotechnology to Participate in a Panel Discussion at TD Cowen’s 44th Annual Health Care ConferenceFebruary 22, 2024 | businesswire.comPuma Biotechnology to Participate in a Panel Discussion at TD Cowen's 44th Annual Health Care ConferenceFebruary 22, 2024 | marketbeat.comFY2025 Earnings Forecast for Puma Biotechnology, Inc. Issued By Zacks Research (NASDAQ:PBYI)Puma Biotechnology, Inc. (NASDAQ:PBYI - Free Report) - Zacks Research raised their FY2025 earnings per share estimates for Puma Biotechnology in a report issued on Monday, February 19th. Zacks Research analyst K. Shah now anticipates that the biopharmaceutical company will earn $0.56 per share foFebruary 21, 2024 | msn.comPuma Biotech (PBYI) Is Up 23.01% in One Week: What You Should KnowFebruary 21, 2024 | marketbeat.comPuma Biotechnology, Inc. (NASDAQ:PBYI) to Post FY2024 Earnings of $0.42 Per Share, Zacks Research ForecastsPuma Biotechnology, Inc. (NASDAQ:PBYI - Free Report) - Investment analysts at Zacks Research increased their FY2024 earnings per share (EPS) estimates for Puma Biotechnology in a research note issued on Monday, February 19th. Zacks Research analyst K. Shah now expects that the biopharmaceutical cFebruary 15, 2024 | finance.yahoo.comPuma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial ResultsFebruary 15, 2024 | businesswire.comPuma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial ResultsFebruary 14, 2024 | marketbeat.comPuma Biotechnology (NASDAQ:PBYI) Stock Rating Lowered by StockNews.comStockNews.com downgraded Puma Biotechnology from a "strong-buy" rating to a "buy" rating in a report on Wednesday.February 13, 2024 | wsj.comPuma Biotechnology Inc. Get Puma Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for PBYI and its competitors with MarketBeat's FREE daily newsletter. Email Address Shocking $16T Elon Musk Crypto Leak (Ad)Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run. Click here now to get your copy. PBYI Media Mentions By Week PBYI Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PBYI News Sentiment▼0.120.76▲Average Medical News Sentiment PBYI News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PBYI Articles This Week▼22▲PBYI Articles Average Week Get Puma Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for PBYI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: RAPT Therapeutics News Today Akebia Therapeutics News Today Marinus Pharmaceuticals News Today UroGen Pharma News Today Phibro Animal Health News Today Nuvation Bio News Today Olema Pharmaceuticals News Today AnaptysBio News Today Mineralys Therapeutics News Today Sage Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PBYI) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersTrump convicted... now what?Unexpected Twist to Trump's Trial Most folks sense there's more to the Trump trial than meets the eye. B...Stansberry Research | Sponsored[PDF Inside] Crypto's $1 Trillion 60-Day Boom + New 2024 Profit StrategyThe crypto industry is exploding and Chris Munch just released a new PDF detailing how you can potentially pro...DeFi Distribution | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredMoonshot Coins for the Current Crypto RunDid you see bitcoin crossed $70k again? Don't miss the next bull run. Because while Bitcoin and Ethereum s...Crypto 101 Media | Sponsored